Pacira BioSciences Inc (NASDAQ:PCRX) shares, rose in value on Friday, February 14, with price down by -4.11% to the previous day’s close as strong demand from buyers drove the stock to $25.44.
Actively observing the price movement in the last trading, the stock closed the session at $26.53, falling within a range of $25.44 and $26.9871. The value of beta (5-year monthly) was 0.8. Referring to stock’s 52-week performance, its high was $31.67, and the low was $11.16. On the whole, PCRX has fluctuated by 16.27% over the past month.
With the market capitalization of Pacira BioSciences Inc currently standing at about $1.17 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 699.88M, with a low estimate of 180.79M and a high estimate of 187.32M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 184.98M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PCRX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of PCRX currently trading nearly -0.19% and 16.21% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.91, while the 7-day volatility ratio is showing 4.69% which for the 30-day chart, stands at 5.42%. Furthermore, Pacira BioSciences Inc (PCRX)’s beta value is 0.85, and its average true range (ATR) is 1.28.
A comparison of Pacira BioSciences Inc (PCRX) with its peers suggests the former has fared considerably weaker in the market. PCRX showed an intraday change of -4.11% in last session, and over the past year, it shrunk by -12.91%%.
Data on historical trading for Pacira BioSciences Inc (NASDAQ:PCRX) indicates that the trading volumes over the past 10 days have averaged 0.72 and over the past 3 months, they’ve averaged 807.08K. According to company’s latest data on outstanding shares, there are 46.15 million shares outstanding.
Nearly 4.53% of Pacira BioSciences Inc’s shares belong to company insiders and institutional investors own 106.85% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.14 million shares as on 2025-01-31, resulting in a short ratio of 5.95. According to the data, the short interest in Pacira BioSciences Inc (PCRX) stood at 1622.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 4.36 million. The stock has risen by 35.03% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PCRX stock heading into the next quarter.
